NephroGenex Company Profile (NASDAQ:NRX)

About NephroGenex

NephroGenex logoNephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NRX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.14
  • 50 Day Moving Average: $0.4029
  • 200 Day Moving Average: $1.1666
  • 52-Week Range: $0.10 - $8.90
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.08
  • P/E Growth: 0.0000
  • Market Cap: $N/A
Additional Links:
Companies Related to NephroGenex:

Analyst Ratings

Consensus Ratings for NephroGenex (NASDAQ:NRX) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $9.00 (6,323.98% upside)

Analysts' Ratings History for NephroGenex (NASDAQ:NRX)
Show:
DateFirmActionRatingPrice TargetDetails
4/15/2016Rodman & RenshawReiterated RatingNeutralView Rating Details
4/8/2016HC WainwrightDowngradeBuy -> NeutralView Rating Details
8/17/2015MLV & Co.Reiterated RatingBuy$20.00View Rating Details
12/31/2014AegisReiterated RatingBuy$15.00View Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for NephroGenex (NASDAQ:NRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/11/2016        
11/11/2015Q315($0.65)($0.53)ViewListenView Earnings Details
8/12/2015Q215($0.56)($0.72)ViewListenView Earnings Details
5/13/2015Q115($0.62)($0.58)ViewN/AView Earnings Details
3/24/2015Q414($0.58)($0.60)ViewN/AView Earnings Details
11/12/2014Q314($0.46)($0.50)ViewN/AView Earnings Details
8/11/2014($0.24)($0.61)ViewN/AView Earnings Details
5/14/2014Q114($0.37)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NephroGenex (NASDAQ:NRX)
Current Year EPS Consensus Estimate: $-0.3000 EPS
Next Year EPS Consensus Estimate: $-1.7100 EPS

Dividends

Dividend History for NephroGenex (NASDAQ:NRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NephroGenex (NASDAQ:NRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/6/2015Ventures V L.P. RhoMajor ShareholderSell273,860$10.58$2,897,438.80View SEC Filing  
11/25/2014Bob PetersonVPBuy2,000$4.20$8,400.00View SEC Filing  
2/14/2014Robert R SeltzerDirectorBuy790,000$12.00$9,480,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for NephroGenex (NASDAQ:NRX)
DateHeadline
capitalcube.com logoNaturex SA :NRX-FR: Earnings Analysis: Q4, 2015 By the Numbers : August 9, 2016 (NASDAQ:NRX)
www.capitalcube.com - August 9 at 9:43 AM
ftsenews.co.uk logoNephroGenex, Inc. (NRX) Updated Price Targets - FTSE News (NASDAQ:NRX)
www.ftsenews.co.uk - July 26 at 9:44 AM
fiscalstandard.com logoNephroGenex, Inc. (NRX) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:NRX)
www.fiscalstandard.com - July 17 at 5:56 PM
fiscalstandard.com logoBrokers Issue Average Price Target Of 17.50 On NephroGenex, Inc. (NRX) - Fiscal Standard (NASDAQ:NRX)
www.fiscalstandard.com - July 9 at 9:45 AM
fiscalstandard.com logoRecently Issued Stock Ratings For NephroGenex, Inc. (NRX) - Fiscal Standard (NASDAQ:NRX)
www.fiscalstandard.com - July 1 at 6:31 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For NephroGenex, Inc. (NRX) - Fiscal Standard (NASDAQ:NRX)
www.fiscalstandard.com - June 28 at 11:21 AM
ftsenews.co.uk logoNew Broker Ratings For NephroGenex, Inc. (NRX) - FTSE News (NASDAQ:NRX)
www.ftsenews.co.uk - June 25 at 10:14 AM
News IconNext Weeks Broker Price Targets For NephroGenex, Inc. (NRX) - Share Trading News (NASDAQ:NRX)
www.sharetrading.news - May 30 at 10:02 PM
realistinvestor.com logoNephroGenex, Inc. (NASDAQ:NRX) Closes At $0.1401 - RealistInvestor.com (NASDAQ:NRX)
www.realistinvestor.com - May 27 at 2:37 PM
feeds.benzinga.com logo3 Companies Filed For Chapter 11 Bankruptcy Today (NASDAQ:NRX)
feeds.benzinga.com - May 2 at 2:37 PM
finance.yahoo.com logoNephroGenex Files For Bankruptcy Protection Under Chapter 11 (NASDAQ:NRX)
finance.yahoo.com - May 2 at 9:43 AM
publicnow.com logoNephroGenex, Inc. Commences Voluntary Chapter 11 Proceeding; Seeks To Initiate Sale Process Under Section 363 (NASDAQ:NRX)
www.publicnow.com - May 2 at 8:20 AM
bizjournals.com logoResearch Triangle area's biotech sector in steep bear market (NASDAQ:NRX)
www.bizjournals.com - April 26 at 3:00 PM
bizjournals.com logoHow NephroGenex went from darling to disaster (NASDAQ:NRX)
www.bizjournals.com - April 14 at 4:30 PM
finance.yahoo.com logoNephroGenex downgraded by H.C. Wainwright (NASDAQ:NRX)
finance.yahoo.com - April 8 at 7:10 AM
finance.yahoo.com logoNATUREX - FY 2015 Results (NASDAQ:NRX)
finance.yahoo.com - March 31 at 2:46 AM
News IconNephroGenex restructuring; INC forecasts $1B in revenue; PRA reports major growth (NASDAQ:NRX)
wraltechwire.com - February 26 at 1:40 PM
biz.yahoo.com logoNEPHROGENEX, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Costs Associated with Exit or D (NASDAQ:NRX)
biz.yahoo.com - February 24 at 4:31 PM
feeds.benzinga.com logoHere's Why NephroGenex Plunged 40% On Wednesday (NASDAQ:NRX)
feeds.benzinga.com - February 24 at 3:16 PM
bizjournals.com logoNephroGenex stock tumbles after announcement to halt trial over consideration of reverse merger (NASDAQ:NRX)
www.bizjournals.com - February 24 at 11:24 AM
finance.yahoo.com logoNephroGenex Provides Corporate Update (NASDAQ:NRX)
finance.yahoo.com - February 24 at 9:20 AM
biz.yahoo.com logoQ4 2015 NephroGenex Inc Earnings Release - After Market Close (NASDAQ:NRX)
biz.yahoo.com - February 24 at 7:07 AM
finance.yahoo.com logoNephroGenex to Host Conference Call and Webcast on Fourth Quarter and Full Year 2015 Financial Results on Thursday, February 25, 2016 (NASDAQ:NRX)
finance.yahoo.com - February 16 at 8:00 AM
News IconLatest Analysts Reports On NephroGenex, Inc. (NRX) - Risers & Fallers (NASDAQ:NRX)
www.risersandfallers.com - February 7 at 2:32 PM
News IconDaily Watch List: NephroGenex (NASDAQ:NRX), Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP), Crescent Point ... - Property Mentor (NASDAQ:NRX)
www.propertymentorgroup.com - February 4 at 3:00 PM
News IconNephroGenex, Inc. (NASDAQ:NRX) Short Interest Update - The Daily Rover (NASDAQ:NRX)
thedailyrover.com - January 29 at 2:23 PM
businesswire.com logoNephroGenex to Present at the 18th Annual BIO CEO & Investor Conference - Business Wire (press release) (NASDAQ:NRX)
www.businesswire.com - January 27 at 1:43 PM
publicnow.com logoNephroGenex to Present at the 18th Annual BIO CEO & Investor Conference (NASDAQ:NRX)
www.publicnow.com - January 27 at 8:26 AM
News IconNephroGenex, Inc. Analyst Rating Update - WallStreet Prudent (NASDAQ:NRX)
www.wallstreetprudent.com - January 26 at 2:19 PM
News IconCompany Shares of NephroGenex, Inc. (NASDAQ:NRX) Drops by -9.82% - Market Briefing (NASDAQ:NRX)
www.marketbriefing.net - January 25 at 1:36 PM
News IconNephroGenex Receives a Buy from Rodman & Renshaw - Markets.co (NASDAQ:NRX)
www.markets.co - January 24 at 12:45 PM
News Icon3 Stocks Jumping on Abnormally High Volume: Cardica, Inc. (CRDC), NephroGenex Inc (NRX), Synergy Resources ... - Street Register (NASDAQ:NRX)
www.streetregister.com - January 24 at 12:45 PM
nasdaq.com logoAMGN Gets FDA Nod, Data Awaits RGLS In Feb, FORWARD Puts ALKS On The Back Foot - Nasdaq (NASDAQ:NRX)
www.nasdaq.com - January 22 at 8:38 PM
streetinsider.com logoPre-Open Stock Movers 01/22: (NRX) (EGHT) (CHK) Higher; (CSII) (LGCY) (DGII) Lower (more...) - StreetInsider.com (NASDAQ:NRX)
www.streetinsider.com - January 22 at 8:38 PM
streetinsider.com logoNephroGenex (NRX) Reports IDSMB Recommendation to Continue Oral Pyridorin Phase 3 as Planned (NASDAQ:NRX)
www.streetinsider.com - January 22 at 8:38 PM
streetinsider.com logoNephroGenex (NRX) Reports IDSMB Recommendation to Continue Oral Pyridorin ... - StreetInsider.com (NASDAQ:NRX)
www.streetinsider.com - January 21 at 8:49 PM
noodls.com logoNephroGenex Announces Independent DSMB Recommendation to Continue Phase 3 Study of Oral Pyridorin in Diabetic Nephropathy Without Modification (NASDAQ:NRX)
www.noodls.com - January 21 at 4:39 PM
finance.yahoo.com logo4:11 pm NephroGenex announces independent DSMB recommendation to continue Phase 3 study of oral Pyridorin in diabetic nephropathy without modification (NASDAQ:NRX)
finance.yahoo.com - January 21 at 4:11 PM
biz.yahoo.com logoNEPHROGENEX, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:NRX)
biz.yahoo.com - January 7 at 4:03 PM
finance.yahoo.com logoNephroGenex to Participate in Two Healthcare Conferences in January (NASDAQ:NRX)
finance.yahoo.com - January 6 at 8:00 AM
finance.yahoo.com logoNephroGenex Announces Formation of Scientific Advisory Board (NASDAQ:NRX)
finance.yahoo.com - January 5 at 8:00 AM
bizjournals.com logoRaleigh drug developer sees shares soar on good news from FDA (NASDAQ:NRX)
www.bizjournals.com - December 14 at 5:40 PM
insidermonkey.com logoWhy Are Investors Piling Into These Stocks? (NASDAQ:NRX)
www.insidermonkey.com - December 14 at 3:58 PM
finance.yahoo.com logoThanks, FDA: NephroGenex Investors Rejoice After New Clearance (NASDAQ:NRX)
finance.yahoo.com - December 14 at 12:52 PM
thestreet.com logoNephroGenex (NRX) Stock Soars After FDA Approves Clinical Trials for Kidney Treatment (NASDAQ:NRX)
www.thestreet.com - December 14 at 11:29 AM
finance.yahoo.com logoNephroGenex Announces FDA Clearance of IND Application for Clinical Study of Intravenous Pyridorin in the Treatment of Acute Kidney Injury (NASDAQ:NRX)
finance.yahoo.com - December 14 at 8:00 AM
finance.yahoo.com logoNEPHROGENEX, INC. Financials (NASDAQ:NRX)
finance.yahoo.com - December 8 at 1:18 PM
biz.yahoo.com logoNEPHROGENEX, INC. Files SEC form 8-K, Financial Statements and Exhibits (NASDAQ:NRX)
biz.yahoo.com - November 13 at 7:14 AM
noodls.com logoNephroGenex Reports Third Quarter 2015 Financial Results (NASDAQ:NRX)
www.noodls.com - November 11 at 4:16 PM

Social

NephroGenex (NASDAQ:NRX) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff